Article
05 Dec 2025
US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates
AUTHORS CONTENT
Article
14 Nov 2025
Rewriting The Rulebook: MHRA's Vision For Rare Disease Therapies
Article
17 Oct 2025
MHRA And NICE Launch Aligned Approvals Pathway
Article
09 Sep 2025
UK Government And Pharmaceutical Industry Fail To Reach Agreement On Amendments To Medicines Pricing Scheme
Article
03 Apr 2025
ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme
Article
09 Oct 2024
A New 2024 Code For The British Pharmaceutical Industry – "The Future Is Orange"
Article
14 Aug 2024
Pharmaceutical Advertising Laws And Regulations England & Wales 2024
Article
16 Jul 2024
What Does The New UK Government Mean For Life Sciences?
Article
12 Jul 2023
BGMA Refused Permission For Judicial Review In Relation To Negotiation Of The Voluntary Scheme
Article
13 Jun 2023
Product Liability Laws And Regulations England & Wales 2023
Article
13 Jun 2023
Product Liability Laws And Regulations An Update On Proposed Changes To The Product Liability Directive 2023
Article
09 Feb 2023
UK PMCPA Publishes Long-awaited Guidance On Use Of Social Media
Article
30 Sep 2022
Concern Over High Scheme Payments Under The UK VPAS
Article
14 Jul 2022
Product Liability 2022
Article
26 Apr 2022
Life Sciences 2022
Article
15 Jul 2021
Pharmaceutical Advertising 2021: England & Wales Chapter
Article
27 Jan 2021
New 2021 Code Of Practice For The British Pharmaceutical Industry
Article
12 Jan 2021
The EU And UK Trade And Co-Operation Agreement: Implications For Life Sciences Companies
Article
22 Jul 2020
Pharmaceutical Advertising Laws And Regulations 2020
Article
21 Jul 2020
An Overview Of EU Rules On Consumer Advertising Of Over-The-Counter Products In The Life Sciences Sector